Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of ALPA LAB. For more details, see the ALPA LAB quarterly results and ALPA LAB share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.3 |
No. of shares | m | 21.04 |
1 Week | % | 8.4 |
1 Month | % | 13.5 |
1 Year | % | 60.0 |
52 week H/L | Rs | 115.0/55.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ALPA LAB EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 42 | 29 | 49 | 109 | 90 | |
Low | Rs | 20 | 11 | 14 | 36 | 49 | |
Sales per share (Unadj.) | Rs | 37.1 | 40.9 | 46.4 | 53.4 | 44.2 | |
Earnings per share (Unadj.) | Rs | 0.5 | 0.9 | 3.4 | 6.7 | 6.0 | |
Diluted earnings per share | Rs | 0.5 | 0.9 | 3.4 | 6.7 | 6.0 | |
Cash flow per share (Unadj.) | Rs | 2.0 | 2.4 | 4.0 | 7.5 | 6.6 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 46.8 | 47.7 | 51.2 | 57.9 | 64.0 | |
Adj. book value per share | Rs | 46.8 | 47.7 | 51.2 | 57.9 | 64.0 | |
Shares outstanding (eoy) | m | 21.04 | 21.04 | 21.04 | 21.04 | 21.04 | |
Price / Sales ratio | x | 0.8 | 0.5 | 0.7 | 1.4 | 1.6 | |
Avg P/E ratio | x | 64.6 | 23.2 | 9.0 | 10.8 | 11.6 | |
P/CF ratio (eoy) | x | 15.8 | 8.6 | 7.7 | 9.7 | 10.5 | |
Price / Book Value ratio | x | 0.7 | 0.4 | 0.6 | 1.3 | 1.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 654 | 430 | 654 | 1,525 | 1,457 | |
Total wages/salary | Rs m | 120 | 118 | 117 | 119 | 122 |
ALPA LAB INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 780 | 860 | 976 | 1,123 | 930 | |
Other income | Rs m | 53 | 29 | 44 | 108 | 94 | |
Total revenues | Rs m | 833 | 889 | 1,020 | 1,230 | 1,023 | |
Gross profit | Rs m | 11 | 34 | 77 | 107 | 81 | |
Depreciation | Rs m | 31 | 32 | 12 | 17 | 13 | |
Interest | Rs m | 6 | 2 | 1 | 2 | 2 | |
Profit before tax | Rs m | 28 | 29 | 108 | 196 | 159 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 17 | 11 | 35 | 55 | 33 | |
Profit after tax | Rs m | 10 | 19 | 72 | 141 | 126 | |
Gross profit margin | % | 1.5 | 3.9 | 7.9 | 9.5 | 8.7 | |
Effective tax rate | % | 63.3 | 36.2 | 32.8 | 28.0 | 20.8 | |
Net profit margin | % | 1.3 | 2.2 | 7.4 | 12.6 | 13.5 |
ALPA LAB BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 941 | 955 | 1,211 | 1,380 | 1,491 | |
Current liabilities | Rs m | 223 | 208 | 325 | 288 | 296 | |
Net working cap to sales | % | 92.0 | 86.9 | 90.8 | 97.3 | 128.6 | |
Current ratio | x | 4.2 | 4.6 | 3.7 | 4.8 | 5.0 | |
Inventory Days | Days | 229 | 242 | 191 | 249 | 326 | |
Debtors Days | Days | 1,404 | 1,044 | 1,326 | 1,237 | 1,835 | |
Net fixed assets | Rs m | 270 | 250 | 193 | 172 | 181 | |
Share capital | Rs m | 210 | 210 | 210 | 210 | 210 | |
"Free" reserves | Rs m | 775 | 793 | 866 | 1,007 | 1,135 | |
Net worth | Rs m | 985 | 1,004 | 1,076 | 1,217 | 1,346 | |
Long term debt | Rs m | 4 | 2 | 0 | 21 | 8 | |
Total assets | Rs m | 1,210 | 1,204 | 1,404 | 1,552 | 1,673 | |
Interest coverage | x | 5.8 | 15.8 | 139.3 | 90.3 | 71.9 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.6 | 0.7 | 0.7 | 0.7 | 0.6 | |
Return on assets | % | 1.3 | 1.7 | 5.2 | 9.2 | 7.7 | |
Return on equity | % | 1.0 | 1.8 | 6.7 | 11.6 | 9.3 | |
Return on capital | % | 3.4 | 3.1 | 10.1 | 16.0 | 11.9 | |
Exports to sales | % | 34.6 | 37.8 | 46.4 | 49.5 | 43.4 | |
Imports to sales | % | 7.1 | 12.1 | 73.6 | 5.7 | 4.6 | |
Exports (fob) | Rs m | 270 | 325 | 453 | 555 | 403 | |
Imports (cif) | Rs m | 56 | 104 | 718 | 64 | 43 | |
Fx inflow | Rs m | 270 | 325 | 453 | 555 | 403 | |
Fx outflow | Rs m | 57 | 107 | 721 | 65 | 46 | |
Net fx | Rs m | 213 | 218 | -268 | 490 | 357 |
ALPA LAB CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -10 | 178 | -17 | 99 | 89 | |
From Investments | Rs m | -147 | -112 | 59 | -156 | 21 | |
From Financial Activity | Rs m | -48 | -13 | 2 | 54 | -38 | |
Net Cashflow | Rs m | -204 | 53 | 43 | -2 | 72 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Mahendra Singh Chawla | COMP SEC: Megha Neema | YEAR OF INC: 1988 | BSE CODE: 532878 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ALPA LAB With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.